85 related articles for article (PubMed ID: 8682466)
1. Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study.
Lygidakis NJ; Stringaris K; Kokinis K; Lyberopoulos K; Raptis S
Hepatogastroenterology; 1996; 43(7):212-20. PubMed ID: 8682466
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
[TBL] [Abstract][Full Text] [Related]
3. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem.
Lygidakis NJ; Ziras N; Parissis J
Hepatogastroenterology; 1995 Apr; 42(2):155-61. PubMed ID: 7672764
[TBL] [Abstract][Full Text] [Related]
4. Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study.
Lygidakis NJ; Sgourakis G; Vlachos L; Raptis S; Safioleas M; Boura P; Kountouras J; Alamani M
Hepatogastroenterology; 2001; 48(42):1685-91. PubMed ID: 11813601
[TBL] [Abstract][Full Text] [Related]
5. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
Leichman CG; Jacobson JR; Modiano M; Daniels JR; Zalupski MM; Doroshow JH; Fletcher WS; Macdonald JS
Cancer; 1999 Sep; 86(5):775-81. PubMed ID: 10463975
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases.
Okuno K; Shigeoka H; Lee YS; Son E; Kayama H; Nakai T; Koh K; Yasutomi M
Hepatogastroenterology; 1996; 43(9):688-91. PubMed ID: 8799416
[TBL] [Abstract][Full Text] [Related]
7. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
[TBL] [Abstract][Full Text] [Related]
9. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi W; Chatzissavvidis I; Valek V
Eur J Surg Oncol; 2001 Nov; 27(7):652-61. PubMed ID: 11669594
[TBL] [Abstract][Full Text] [Related]
10. Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone.
Popov IP; Milicevic M; Kecmanovic D; Tomasevic Z; Radosevic-Jelic Lj; Borojevic N; Micev MT; Kezic I
J Exp Clin Cancer Res; 2006 Sep; 25(3):313-9. PubMed ID: 17167970
[TBL] [Abstract][Full Text] [Related]
11. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
12. Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study.
Lygidakis NJ; Sgourakis G; Dedemadi G; Safioleus MC; Nestoridis J
Hepatogastroenterology; 2001; 48(40):1085-7. PubMed ID: 11490806
[TBL] [Abstract][Full Text] [Related]
13. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study on the effects of lipiodolization before a potentially curative hepatectomy for colorectal liver metastases: long-term results of a pilot study.
Utsunomiya T; Emi Y; Ikejiri K; Suzuki M; Saitsu H; Yakabe S; Nonaka M; Saku M; Yoshida K; Shimada M; Sugimachi K
Hepatogastroenterology; 2001; 48(39):790-3. PubMed ID: 11462925
[TBL] [Abstract][Full Text] [Related]
15. [Personal experience with intra-arterial locoregional chemotherapy of liver metastases from colorectal carcinoma].
Kiss I; Marková J; Tomásek J; Vyzula R; Válek V; Boudný J; Kala Z; Hanke I; Ostrízek T; Leypold J
Vnitr Lek; 2001 Dec; 47(12):829-33. PubMed ID: 11826545
[TBL] [Abstract][Full Text] [Related]
16. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
da Silva RG; Sugarbaker PH
J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
Salman HS; Cynamon J; Jagust M; Bakal C; Rozenblit A; Kaleya R; Negassa A; Wadler S
Clin Colorectal Cancer; 2002 Nov; 2(3):173-9. PubMed ID: 12482334
[TBL] [Abstract][Full Text] [Related]
18. Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach.
Sperti E; Faggiuolo R; Gerbino A; Magnino A; Muratore A; Ortega C; Ferraris R; Leone F; Capussotti L; Aglietta M
Dis Colon Rectum; 2006 Oct; 49(10):1596-601. PubMed ID: 16988853
[TBL] [Abstract][Full Text] [Related]
19. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
Lygidakis NJ; Konstantinidou T; Pothoulakis J
Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer metastases: surgical indications and multimodal approach.
Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
